CHRS
Coherus BioSciences Inc
1.20$
+0.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -99.5% | -80.9% | +766.5% | +0.0% | +11.5% | -100.0% | – | – | – | – | +124.9% | +33.9% | +10.9% | -6.2% | +16.8% | -16.3% | -2.8% | -24.8% | +5.6% | -5.9% | -11.1% | -18.1% | +0.1% | -24.5% | -0.2% | -28.5% | +81.0% | +27.0% | +22.7% | -97.5% | +2,715.4% | +8.9% | -23.5% | -86.0% | +34.9% | +12.8% | +10.2% | -3.4% | +16.2% | – | |
| – | -8.6% | -8.9% | -38.3% | +28.4% | -27.4% | -17.7% | +4.2% | +4.6% | -3.9% | -91.7% | -73.0% | +972.7% | +21.1% | -12.2% | +47.9% | -11.2% | +29.7% | -35.7% | +122.3% | +27.5% | -43.1% | -22.6% | +20.4% | +212.4% | -59.7% | +18.8% | +47.3% | +31.6% | +158.6% | -98.3% | +1,953.9% | -29.8% | +63.2% | -89.1% | +19.2% | +6.3% | +5.4% | -5.0% | -9.6% | – | |
| – | -159.2% | – | – | – | – | – | – | – | – | – | +137.5% | +27.0% | +10.3% | -5.8% | +14.8% | -16.7% | -5.6% | -23.5% | -6.1% | -13.7% | +0.1% | -17.2% | -3.7% | -79.2% | +205.7% | -50.0% | +117.6% | +23.6% | -83.4% | -87.5% | +3,976.4% | +41.2% | -59.5% | -80.8% | +49.8% | +17.8% | +13.4% | -2.5% | +32.2% | – | |
| – | -8.6% | -8.9% | -35.8% | +23.6% | -26.1% | -19.2% | +4.2% | +19.2% | -15.6% | -29.5% | +0.5% | +14.2% | +62.0% | -5.3% | -20.9% | +48.4% | +14.9% | +356.0% | -73.1% | -1.2% | -6.1% | +63.3% | -49.8% | +10.1% | -36.6% | +17.7% | -31.9% | +10.2% | +2.8% | +7.8% | -26.9% | +4.4% | -2.0% | +9.8% | +8.5% | +3.9% | +14.4% | -31.3% | +3.8% | – | |
| – | +12.1% | +22.9% | +25.2% | -40.6% | +7.1% | +10.7% | +10.9% | +37.9% | +22.4% | +5.3% | +11.5% | -12.7% | -0.8% | +12.0% | -3.7% | -6.1% | +6.0% | +16.2% | +2.4% | -1.0% | +3.6% | +17.9% | +5.2% | -12.6% | -3.8% | +14.0% | -8.2% | +6.8% | -23.9% | +54.1% | -37.8% | -1.2% | -31.8% | +9.8% | +0.1% | -4.3% | -5.3% | -2.1% | -9.3% | – | |
| – | -5.0% | -2.3% | -20.0% | -2.4% | -17.9% | -9.5% | +6.8% | +26.9% | +6.2% | -14.9% | +7.5% | -3.5% | +33.0% | -3.6% | -12.0% | +17.6% | +16.2% | +195.0% | -60.8% | -1.2% | +7.2% | +30.6% | -29.5% | -2.4% | -8.8% | +0.8% | -17.9% | +8.0% | +2.7% | -9.5% | -18.5% | +0.9% | +10.8% | -21.1% | +4.0% | -4.3% | +9.3% | -18.5% | -3.1% | – | |
| – | -186.8% | – | – | – | – | – | – | – | – | – | – | +88.6% | -13.1% | -9.2% | +59.8% | -48.4% | -51.3% | -1,118.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.1% | +0.3% | +0.3% | +0.3% | +0.3% | +0.3% | +0.4% | +0.3% | +0.4% | +73.2% | +5.1% | +0.8% | +0.3% | -1.2% | +22.0% | +4.6% | +0.3% | -0.4% | +1.8% | +0.4% | +0.4% | +54.8% | -26.6% | +14.6% | +24.5% | +3.5% | +2.4% | +3.3% | +3.4% | +4.7% | -52.0% | +0.5% | -0.3% | -59.8% | +5.9% | +2.1% | -3.3% | -2.8% | +6.3% | – | |
| – | -190.6% | – | – | – | – | – | – | – | – | – | – | +102.8% | -13.8% | -11.5% | +65.3% | -53.4% | -61.7% | -1,707.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -89.2% | +438.1% | +157.8% | -59.5% | -95.3% | +2,128.9% | +136.6% | -50.5% | -97.6% | +7,081.4% | -99.0% | +1,560.8% | +141.3% | -54.4% | +38.7% | -85.9% | +474.9% | +442.7% | +0.9% | +0.7% | -0.1% | +161.7% | -59.5% | +1.0% | +19.0% | -112.9% | – | -103.3% | – | – | – | – | – | – | -3,836.0% | – | – | – | -1,013.5% | – | |
| – | -190.4% | – | – | – | – | – | – | – | – | – | – | +99.6% | -16.6% | -9.3% | +65.9% | -52.7% | -65.2% | -1,881.5% | – | – | – | – | – | – | – | – | – | – | – | – | -112.6% | – | – | – | – | – | – | – | – | – | |
| – | -183.6% | – | – | – | – | – | – | – | – | – | – | +88.9% | -12.0% | -11.2% | +60.0% | -48.2% | -49.9% | -1,063.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.